Free Trial

Amplifon (OTCMKTS:AMFPF) Trading 1.2% Higher - Time to Buy?

Amplifon logo with Medical background

Key Points

  • Amplifon's shares rose by 1.2% on Wednesday, trading at $17.46, with a significant increase in trading volume of 1,382% from the average session volume.
  • Morgan Stanley reaffirmed an "overweight" rating for Amplifon, indicating a positive outlook on the stock.
  • The company is valued at $3.94 billion and specializes in distributing hearing solutions globally, with a diverse range of hearing devices offered.
  • Need Better Tools to Track Amplifon? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) shares rose 1.2% during trading on Wednesday . The stock traded as high as $17.46 and last traded at $17.46. Approximately 23,018 shares changed hands during mid-day trading, an increase of 1,382% from the average daily volume of 1,553 shares. The stock had previously closed at $17.25.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reiterated an "overweight" rating on shares of Amplifon in a report on Wednesday, June 25th.

Get Our Latest Stock Analysis on AMFPF

Amplifon Price Performance

The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 25.68 and a beta of 0.53. The stock's 50 day moving average is $22.80 and its 200 day moving average is $23.01. The company has a quick ratio of 0.54, a current ratio of 0.62 and a debt-to-equity ratio of 0.85.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.09). The firm had revenue of $698.20 million for the quarter, compared to analyst estimates of $625.73 million. Amplifon had a net margin of 5.90% and a return on equity of 13.77%.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Featured Articles

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines